Global Sarcoma Biopsy Market, by Product Type (Reusable Device and Disposable Devices), by End User (Hospitals, Ambulatory Surgical Centers, and Diagnostic Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued at US$ 192.55 million in 2019, and is expected to exhibit a CAGR of 2.8% over the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.
Global sarcoma biopsy market is expected to witness to significant growth during the forecast period, owing to increasing technological advancements in the field of biopsy. For instance, in November 2015, Cook Medical launched its new EchoTip ProCore 20 gage needle with ReCoil Stylet, which will help the physicians to collect the blood samples from the rom difficult anatomical locations. Ecotip ProCore has core-trap technology, which will allow the physicians to collect samples during the minimally invasive procedure.
Furthermore, in October 2017, European Commission approved the acquisition of C.R Bard by Becton Dickinson Company. This acquisition helped the company to manufacture new medical devices and technology, which will be utilized to cure many serious conditions such as cancer.
* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/3819
Browse 26 Market Data Tables and 25 Figures spread through 151 Pages and in-depth TOC on Global Sarcoma Biopsy Market, by Product Type (Reusable Device and Disposable Devices), by End User (Hospitals, Ambulatory Surgical Centers, and Clinics), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Forecast to 2027"
Increasing prevalence of osteosarcoma is expected to drive growth of the global sarcoma biopsy market.
Osteosarcoma is the most common type of cancer affecting bones, and it mostly occurs in children and young adults. On the basis of cells, osteosarcoma is classified as high-, intermediate- and low-grade. For instance, according to the American Cancer Society, IN January 2020, around 800 to 900 new cases of osteosarcoma are diagnosed in the U.S. each year, with around 50% occurs in children and teenagers.
Global Sarcoma Biopsy Market– Regional Analysis
North America accounted for the largest market share in the global sarcoma biopsy market, owing to rising healthcare expenditure in the U.S. For instance, according to the Committee for a Responsible Federal Budget, in 2017, the U.S. spent around US $ 3.5 trillion, or 18% of the total GDP, on health expenditures, which is more than twice the average among developed countries.
Browse Research Report: https://www.coherentmarketinsights.com/market-insight/sarcoma-biopsy-market-3819
Key Takeaways of the Global Sarcoma Biopsy Market:
The global sarcoma Biopsy market is expected to exhibit a CAGR of 2.8% over the forecast period (2020-2027), owing to increasing technological advancements in the field of biopsy.
Kaposi sarcoma being one of the sarcoma condition is much more common among men than women, and is rarely observed among children. For instance, according to the American Cancer Society (ACS), February 2016 data findings, around 1 in 200 transplant patients in the U.S. suffer from Kaposi sarcoma. In the U.S.
Major players operating in the global sarcoma biopsy market include R. Bard, Inc., Becton, Dickinson and Company, Argon Medical Devices, InVivo Therapeutics Corporation, Cook Medical Incorporated, UROMED, and Sterylab
Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/3819
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Name: Mr. Shah
Coherent Market Insights 1001 4th Ave,
# 3200 Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737